Wednesday, September 23, 2026

TagsSonrotoclax

Tag: Sonrotoclax

Healthcare

BeOne Medicines' BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma

BFN's Desk - May 14, 2026 0

Corporate

BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership

BFN's Desk - February 26, 2026 0

Most Read

House of McDowell’s Soda Reimagines Yaari with ‘Yaari Ki Nayi Vibe’

September 20, 2026

Black Dog Scotch Whisky In New Packaging

September 11, 2026

Madhya Pradesh Unveils Roadmap to Cut Major Non-CO₂ Pollutants

September 8, 2026

Sanchi Gets a New Identity in Indore, Reinforcing Its 45-Year Legacy of Trust

August 26, 2026